Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Ascites Market

ID: MRFR/HC/54590-HCR
200 Pages
Satyendra Maurya
Last Updated: March 30, 2026

France Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Ascites Market Infographic
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 France Ascites Market, BY Application (USD Million)
      1. 4.1.1 Diagnostic
      2. 4.1.2 Therapeutic
      3. 4.1.3 Prognostic
      4. 4.1.4 Research
    2. 4.2 France Ascites Market, BY Type of Ascites (USD Million)
      1. 4.2.1 Transudative
      2. 4.2.2 Exudative
      3. 4.2.3 Malignant
      4. 4.2.4 Cirrhotic
    3. 4.3 France Ascites Market, BY Treatment Method (USD Million)
      1. 4.3.1 Paracentesis
      2. 4.3.2 Diuretics
      3. 4.3.3 Surgical Intervention
      4. 4.3.4 Transjugular Intrahepatic Portosystemic Shunt
    4. 4.4 France Ascites Market, BY Patient Demographics (USD Million)
      1. 4.4.1 Age Group
      2. 4.4.2 Gender
      3. 4.4.3 Underlying Conditions
      4. 4.4.4 Socioeconomic Status
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the France Ascites Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the France Ascites Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Bristol-Myers Squibb (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Novartis (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Sanofi (FR)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Merck & Co. (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Amgen (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Gilead Sciences (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 AbbVie (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION
    3. 6.3 FRANCE MARKET ANALYSIS BY TYPE OF ASCITES
    4. 6.4 FRANCE MARKET ANALYSIS BY TREATMENT METHOD
    5. 6.5 FRANCE MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    6. 6.6 KEY BUYING CRITERIA OF FRANCE ASCITES MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF FRANCE ASCITES MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: FRANCE ASCITES MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: FRANCE ASCITES MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: FRANCE ASCITES MARKET
    12. 6.12 FRANCE ASCITES MARKET, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 FRANCE ASCITES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 FRANCE ASCITES MARKET, BY TYPE OF ASCITES, 2024 (% SHARE)
    15. 6.15 FRANCE ASCITES MARKET, BY TYPE OF ASCITES, 2024 TO 2035 (USD Million)
    16. 6.16 FRANCE ASCITES MARKET, BY TREATMENT METHOD, 2024 (% SHARE)
    17. 6.17 FRANCE ASCITES MARKET, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 FRANCE ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    19. 6.19 FRANCE ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY TYPE OF ASCITES, 2026-2035 (USD Million)
      3. 7.2.3 BY TREATMENT METHOD, 2026-2035 (USD Million)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

France Ascites Market Segmentation

France Ascites Market By Application (USD Million, 2022-2035)

  • Diagnostic
  • Therapeutic
  • Prognostic
  • Research

France Ascites Market By Type of Ascites (USD Million, 2022-2035)

  • Transudative
  • Exudative
  • Malignant
  • Cirrhotic

France Ascites Market By Treatment Method (USD Million, 2022-2035)

  • Paracentesis
  • Diuretics
  • Surgical Intervention
  • Transjugular Intrahepatic Portosystemic Shunt

France Ascites Market By Patient Demographics (USD Million, 2022-2035)

  • Age Group
  • Gender
  • Underlying Conditions
  • Socioeconomic Status

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓